Commonwealth Coat of Arms of Australia
 

 

PB 85 of 2020

 

National Health (Originator Brand) Amendment Determination 2020 (No. 5)

 I, Thea Daniel, Assistant Secretary, Pricing and PBS Policy Branch, Technology Assessment and Access Division, Department of Health, delegate of the Minister for Health, make the following Determination.

Dated 26 August 2020  

THEA DANIEL

Assistant Secretary

Pricing and PBS Policy Branch

Technology Assessment and Access Division

Department of Health

 

 

 

 

 

 

 

 

 

 

 

Contents

1 Name

2 Commencement

3 Authority

4 Schedules

Schedule 1—Amendments 2

National Health (Originator Brand) Determination 2015 (PB 100 of 2015)  2

 

 

1  Name

  This instrument is the National Health (Originator Brand) Amendment Determination 2020 (No. 5).

  This instrument may also be cited as PB 85 of 2020.

2  Commencement

 (1) Each provision of this instrument specified in column 1 of the table commences, or is taken to have commenced, in accordance with column 2 of the table. Any other statement in column 2 has effect according to its terms.

 

Commencement information

Column 1

Column 2

Column 3

Provisions

Commencement

Date/Details

1.  The whole of this instrument

 1 September 2020

 

Note: This table relates only to the provisions of this instrument as originally made. It will not be amended to deal with any later amendments of this instrument.

 (2) Any information in column 3 of the table is not part of this instrument. Information may be inserted in this column, or information in it may be edited, in any published version of this instrument.

3  Authority

  This instrument is made under subsection 99ADB(6B) of the National Health Act 1953

4  Schedules

  Each instrument that is specified in a Schedule to this instrument is amended or repealed as set out in the applicable items in the Schedule concerned, and any other item in a Schedule to this instrument has effect according to its terms.

Schedule 1—Amendments

National Health (Originator Brand) Determination 2015 (PB 100 of 2015)

1  Schedule 1, (table item 143)

Repeal the items:

143

Metformin

Diabex

Diabex 850

Diabex 1000

Diabex XR

Diabex XR 1000

 

 

Substitute:

143

Metformin

Diabex

Diabex 850

Diabex 1000

Diabex XR 500

Diabex XR 1000

 

 

2  Schedule 1, (table item 156)

Repeal the items:

156

Morphine

Hospira Pty Limited

Injection

 

 

 

MS Contin

MS Contin Suspension 100 mg

MS Contin Suspension 20 mg

MS Contin Suspension 200 mg

MS Contin Suspension 30 mg

MS Contin Suspension 60 mg

 

 

Substitute:

156

Morphine

DBL Morphine Pentahydrate

Injection

 

 

 

MS Contin

MS Contin Suspension 100 mg

MS Contin Suspension 20 mg

MS Contin Suspension 200 mg

MS Contin Suspension 30 mg

MS Contin Suspension 60 mg

 

 

3  Schedule 1, (table item 207)

Repeal the items:

207

Salbutamol

Ventolin Rotacaps

Ventolin CFCfree

Ventolin

Ventolin Nebules

 

 

Substitute:

207

Salbutamol

Ventolin Rotacaps

Ventolin CFCfree

Ventolin CFC-Free with dose counter

Ventolin Nebules

 

 

4  Schedule 1, (table item 229A)

Repeal the items:

229A

Tobramycin

Hospira Pty Limited

Pfizer Australia Pty Ltd

Injection

 

Tobi

Inhalation

 

TOBI podhaler

Inhalation by mouth

 

Tobrex

Application to the eye

 

Substitute:

229A

Tobramycin

DBL Tobramycin

Pfizer Australia Pty Ltd

Injection

 

Tobi

Inhalation

 

TOBI podhaler

Inhalation by mouth

 

Tobrex

Application to the eye